{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.307","value":"3.06"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"}],"units":"Participants"}],"description":"Results from assessing the half-life of Tazemetostat and its metabolite shown below","dispersionType":"Standard Deviation","groups":[{"description":"Oral Tazemetostat 800mg BID\n\nTazemetostat: Tazemetostat (EPZ-6438) is a selective small molecule inhibitor of the histone-lysine methyltransferase EZH2 gene.","id":"OG000","title":"Part 1(Pharmacokinetics)"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 15: pre-dose, 0.5, 1, 2, 4, 6, 8, 10, and 12 post-dose","title":"Part 1: Pharmacokinetics Profile of Tazemetostat and Its Metabolite (Plasma): t1/2","type":"PRIMARY","unitOfMeasure":"Hour"}